T50.4X5 Category · further specificity required Adverse effect of drugs affecting uric acid metabolism
ICD-10-CM T50.4X5 identifies “Adverse effect of drugs affecting uric acid metabolism” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T50 · Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances
Seventh character1
The appropriate 7th character is to be added to each code from category T50
A — initial encounter
D — subsequent encounter
S — sequela
More specific codes
Official index references
Official index references (19)
Allopurinol (1)
- AllopurinolDrugs and chemicals
Atophan (1)
- AtophanDrugs and chemicals
Benemid (1)
- BenemidDrugs and chemicals
Benzbromarone (1)
- BenzbromaroneDrugs and chemicals
Cinchophen (1)
- CinchophenDrugs and chemicals
Colchicine (1)
- ColchicineDrugs and chemicals
Etebenecid (1)
- EtebenecidDrugs and chemicals
Ethebenecid (1)
- EthebenecidDrugs and chemicals
Neocinchophen (1)
- NeocinchophenDrugs and chemicals
Oxipurinol (1)
- OxipurinolDrugs and chemicals
Phenoquin (1)
- PhenoquinDrugs and chemicals
Probenecid (1)
- ProbenecidDrugs and chemicals
Spindle inactivator (1)
- Spindle inactivatorDrugs and chemicals
Sulfinpyrazone (1)
- SulfinpyrazoneDrugs and chemicals
Sulphinpyrazone (1)
- SulphinpyrazoneDrugs and chemicals
Tisopurine (1)
- TisopurineDrugs and chemicals
Urate oxidase (1)
- Urate oxidaseDrugs and chemicals
Uric acid metabolism drug NEC (1)
- Uric acid metabolism drug NECDrugs and chemicals
Uricosuric agent (1)
- Uricosuric agentDrugs and chemicals
History
Code history
Latest recorded change · FY2025 · 04-01
Effective from
- Inherited rules changed
Adverse effect of drugs affecting uric acid metabolism
Category — select a more specific code
CDC/NCHS · FY2025 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.